For: | Chen MY, Juengpanich S, Hu JH, Topatana W, Cao JS, Tong CH, Lin J, Cai XJ. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma. World J Gastroenterol 2020; 26(10): 1042-1055 [PMID: 32205995 DOI: 10.3748/wjg.v26.i10.1042] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i10/1042.htm |
Number | Citing Articles |
1 |
Anxin Chen, Shijie Li, Zhiyuan Yao, Jiahao Hu, Jiasheng Cao, Win Topatana, Sarun Juengpanich, Hong Yu, Jiliang Shen, Mingyu Chen. Adjuvant transarterial chemoembolization to sorafenib in unresectable hepatocellular carcinoma: A meta‐analysis. Journal of Gastroenterology and Hepatology 2021; 36(2): 302 doi: 10.1111/jgh.15180
|
2 |
Xinming Li, Xiangjing Liang, Zhipeng Li, Jianye Liang, Zhendong Qi, Liming Zhong, Zhijun Geng, Wen Liang, Xianyue Quan, Changhong Liang, Zaiyi Liu. A novel stratification scheme combined with internal arteries in CT imaging for guiding postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a retrospective cohort study. International Journal of Surgery 2024; doi: 10.1097/JS9.0000000000001191
|
3 |
Yuxin Liang, Ruoyi Yang, Jin Shang, Deyuan Zhong, Qinyan Yang, Yuhao Su, Ying Shi, Xiaolun Huang. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE. Journal of Cancer Research and Clinical Oncology 2023; 149(18): 16461 doi: 10.1007/s00432-023-05413-7
|
4 |
Guo-Ying Feng, Zheng-Rong Shi, Yu-Fei Zhao, Kai Chen, Jie Tao, Xu-Fu Wei, Yu Cheng. Therapeutic effect of postoperative adjuvant transcatheter arterial chemoembolization based on the neutrophil-to-lymphocyte ratio. Frontiers in Surgery 2023; 9 doi: 10.3389/fsurg.2022.1072451
|
5 |
Jianwei Liu, Minmin Sun, Kunpeng Fang, Jie Wang, Bowen Ma, Li Song, Ting Liu, Ming Tang, Kui Wang, Yong Xia. Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe. Journal of Hepatocellular Carcinoma 2023; : 997 doi: 10.2147/JHC.S412554
|
6 |
Ali Mo, Qiao Zhang, Feng Xia, Zhiyuan Huang, Shasha Peng, Wenjing Cao, Hongliang Mei, Li Ren, Yang Su, Hengyi Gao, Weiqiang Chen. Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study. Cancer Medicine 2023; 12(7): 7734 doi: 10.1002/cam4.5529
|
7 |
Jie Tao, Xiaoli Shi, Xu Feng, Xinhua Wu, Shiguai Qi, Guoying Feng, Xu Yang, Yufei Zhao, Hangjia Zuo, Zhengrong Shi. Development and Validation of a Risk Prediction Algorithm for
Evaluating the Efficacy of Postoperative Adjuvant TACE Therapy for
Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2024; 27(8): 1111 doi: 10.2174/1386207326666230824090204
|
8 |
Weixing Wang, Jun Li, Changjun Pan, Deguo Wang, Jian Dong. miR-328-3p suppresses hepatocellular carcinoma progression by regulating HMOX1 expression. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01610-z
|
9 |
Desheng Chen, Qi Zhu, Tiewen Li, Xuhui Fan, Yichao Lou, Yi Zhang, Kejie Huang, Hongcheng Sun. KLF4 loss in hepatocellular carcinoma: Improving prognostic prediction and correlating immune infiltrates. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1106952
|
10 |
Xinyue Tu, Jie Zhang, Minjun Li, Fei Lu, Ting Wang, Wenfeng Gong, Bangde Xiang. Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma 2023; : 1881 doi: 10.2147/JHC.S422565
|
11 |
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna C. Goussia, Dimitrios K. Christodoulou, Georgios K. Glantzounis. Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC). Cancers 2025; 17(5): 842 doi: 10.3390/cancers17050842
|